Middle East respiratory syndrome (MERS) is a severe viral respiratory infection caused by the Middle East respiratory syndrome coronavirus (MERS-CoV), a zoonotic betacoronavirus first isolated in 2012 from a patient in Saudi Arabia who died of pneumonia and renal failure. Dromedary camels are the reservoir for human spillover, and limited human-to-human transmission occurs, particularly in health-care settings. MERS-CoV enters host cells using dipeptidyl peptidase 4 (DPP4/CD26) as its receptor and causes a spectrum from asymptomatic infection to severe pneumonia, acute respiratory distress syndrome, and multiorgan failure, with a high case-fatality rate concentrated in older adults with comorbidities.
Ask a research question about Middle East Respiratory Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Middle East Respiratory Syndrome
creation_date: "2026-06-28T00:00:00Z"
description: >
Middle East respiratory syndrome (MERS) is a severe viral respiratory infection
caused by the Middle East respiratory syndrome coronavirus (MERS-CoV), a
zoonotic betacoronavirus first isolated in 2012 from a patient in Saudi Arabia
who died of pneumonia and renal failure. Dromedary camels are the reservoir for
human spillover, and limited human-to-human transmission occurs, particularly in
health-care settings. MERS-CoV enters host cells using dipeptidyl peptidase 4
(DPP4/CD26) as its receptor and causes a spectrum from asymptomatic infection to
severe pneumonia, acute respiratory distress syndrome, and multiorgan failure,
with a high case-fatality rate concentrated in older adults with comorbidities.
category: Infectious Disease
parents:
- Viral Respiratory Infection
synonyms:
- MERS
- MERS-CoV infection
- Middle East respiratory syndrome coronavirus infection
disease_term:
preferred_term: Middle East respiratory syndrome
term:
id: MONDO:0100116
label: Middle East respiratory syndrome
pathophysiology:
- name: MERS-CoV Spike-Mediated Entry via DPP4
conforms_to: "host_directed_antiviral_dependency#Host Receptor and Protease Engagement"
description: >
MERS-CoV enters host cells through its spike (S) glycoprotein, whose
receptor-binding S1 domain engages the host cell-surface enzyme dipeptidyl
peptidase 4 (DPP4, also known as CD26); host serine proteases then prime the
spike for membrane fusion. DPP4 is expressed on respiratory epithelium and
pneumocytes, defining the tropism for the lower respiratory tract, and is
also expressed on renal and intestinal epithelium and liver — a tissue
distribution consistent with the extrapulmonary (notably renal and
gastrointestinal) manifestations of severe MERS. Receptor engagement is
independent of DPP4 enzymatic activity: clinically used gliptin DPP4
inhibitors do not block infection, so DPP4 serves as an attachment protein
rather than through its peptidase catalysis. Because the receptor is a host
protein, antibodies against DPP4 block infection — the host-directed-target
logic shared with SARS-CoV-2/ACE2.
genes:
- preferred_term: DPP4
term:
id: hgnc:3009
label: DPP4
cell_types:
- preferred_term: bronchial epithelial cell
term:
id: CL:0002328
label: bronchial epithelial cell
- preferred_term: pulmonary alveolar type 2 cell
term:
id: CL:0002063
label: pulmonary alveolar type 2 cell
biological_processes:
- preferred_term: virion attachment to host cell
term:
id: GO:0019062
label: virion attachment to host cell
- preferred_term: symbiont entry into host cell
term:
id: GO:0046718
label: symbiont entry into host cell
evidence:
- reference: PMID:23486063
reference_title: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Here we identify dipeptidyl peptidase 4 (DPP4; also known as CD26) as a
functional receptor for hCoV-EMC.
explanation: >-
Identifies DPP4 (CD26) as the functional host receptor for MERS-CoV
(hCoV-EMC), the druggable host-factor entry step. Evidence source is IN_VITRO
as this is a cell-based receptor-identification study.
- reference: PMID:23486063
reference_title: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Antibodies directed against DPP4 inhibited hCoV-EMC infection of primary
human bronchial epithelial cells and Huh-7 cells.
explanation: >-
Shows that blocking the host DPP4 receptor inhibits MERS-CoV infection of
human bronchial epithelial cells, the host-directed antiviral proof of
principle. Evidence source is IN_VITRO as this is a cell-culture experiment.
- reference: PMID:23486063
reference_title: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
In humans it is primarily expressed on the epithelial cells in kidney,
small intestine, liver and prostate, and on activated leukocytes
explanation: >-
DPP4 tissue distribution — including renal, intestinal, and hepatic
epithelium — is consistent with the extrapulmonary (renal and
gastrointestinal) tropism of MERS beyond the respiratory tract. Evidence
source is IN_VITRO as this receptor-characterization study reports the
distribution of the host entry protein.
- reference: PMID:23486063
reference_title: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
hCoV-EMC infection could not be blocked by the DPP4 inhibitors sitagliptin,
vildagliptin, saxagliptin or P32/98
explanation: >-
MERS-CoV entry depends on DPP4 as an attachment receptor rather than on its
peptidase catalytic activity: clinically used gliptin DPP4 inhibitors did
not block infection. Evidence source is IN_VITRO as this is a cell-culture
inhibitor experiment.
downstream:
- target: Severe Lower Respiratory Infection and Systemic Spread
description: >-
Productive infection of the lower respiratory epithelium drives severe
pneumonia that can progress to ARDS and multiorgan involvement.
- name: Severe Lower Respiratory Infection and Systemic Spread
description: >
MERS-CoV replication in the lower respiratory tract produces severe pneumonia
that frequently progresses to acute respiratory distress syndrome and
respiratory failure. Systemic and extrapulmonary involvement — notably acute
kidney injury and gastrointestinal symptoms — is common, and the disease
carries a high case-fatality rate concentrated in older adults with
comorbidities.
biological_processes:
- preferred_term: viral genome replication
term:
id: GO:0019079
label: viral genome replication
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
locations:
- preferred_term: lung
term:
id: UBERON:0002048
label: lung
evidence:
- reference: PMID:23075143
reference_title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A previously unknown coronavirus was isolated from the sputum of a
60-year-old man who presented with acute pneumonia and subsequent renal
failure with a fatal outcome in Saudi Arabia.
explanation: >-
The index MERS case establishes the core severe phenotype — acute pneumonia
with renal failure and a fatal outcome. Evidence source is HUMAN_CLINICAL as
this is a clinical case report.
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Disease caused by MERS-CoV presents with a wide range of clinical
manifestations and is associated with substantial mortality in admitted
patients who have medical comorbidities.
explanation: >-
Descriptive cohort of 47 cases establishing the wide clinical spectrum and
substantial mortality in comorbid patients. Evidence source is HUMAN_CLINICAL
as this is a clinical case series.
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
28 patients died, a 60% case-fatality rate. The case-fatality rate rose
with increasing age.
explanation: >-
Quantifies the high case-fatality of hospitalized MERS in the primary Saudi
cohort and its rise with age, supporting the severe outcome and
age-dependent mortality. Evidence source is HUMAN_CLINICAL as this is a
clinical case series.
downstream: []
phenotypes:
- category: Respiratory
name: Pneumonia
description: >
Severe viral pneumonia is the defining manifestation of symptomatic MERS.
phenotype_term:
preferred_term: Pneumonia
term:
id: HP:0002090
label: Pneumonia
evidence:
- reference: PMID:23075143
reference_title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A previously unknown coronavirus was isolated from the sputum of a
60-year-old man who presented with acute pneumonia and subsequent renal
failure with a fatal outcome in Saudi Arabia.
explanation: >-
The index case presented with acute pneumonia. Evidence source is
HUMAN_CLINICAL as this is a clinical case report.
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All patients had abnormal findings on chest radiography, ranging from
subtle to extensive unilateral and bilateral abnormalities.
explanation: >-
Every patient in the 47-case cohort had abnormal chest radiography,
reflecting the near-universal pulmonary involvement of symptomatic MERS.
Evidence source is HUMAN_CLINICAL as this is a clinical case series.
- category: Constitutional
name: Fever
description: >
Fever is the most common presenting symptom of MERS.
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
frequency: VERY_FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Common symptoms at presentation were fever (46 [98%])
explanation: >-
Fever was the most common presenting symptom in the 47-case series, present
in 46 of 47 (98%), supporting a VERY_FREQUENT band. Evidence source is
HUMAN_CLINICAL as this is a clinical case series.
- category: Respiratory
name: Cough
description: >
Cough is a common presenting symptom of MERS, reported in the majority of the
47-case Saudi series.
phenotype_term:
preferred_term: Cough
term:
id: HP:0012735
label: Cough
frequency: VERY_FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
cough (39 [83%])
explanation: >-
Cough was present in 39 of 47 patients (83%) in the primary Saudi cohort,
supporting a VERY_FREQUENT band. Evidence source is HUMAN_CLINICAL as this
is a clinical case series.
- category: Respiratory
name: Dyspnea
description: >
Shortness of breath is a frequent presenting symptom and reflects progression
to severe lower respiratory disease.
phenotype_term:
preferred_term: Dyspnea
term:
id: HP:0002094
label: Dyspnea
frequency: FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
shortness of breath (34 [72%])
explanation: >-
Shortness of breath (dyspnea) was present in 34 of 47 patients (72%) in the
primary Saudi cohort, supporting a FREQUENT band. Evidence source is
HUMAN_CLINICAL as this is a clinical case series.
- category: Renal
name: Acute Kidney Injury
description: >
Renal failure is a characteristic extrapulmonary complication of severe MERS.
phenotype_term:
preferred_term: Acute kidney injury
term:
id: HP:0001919
label: Acute kidney injury
evidence:
- reference: PMID:23075143
reference_title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A previously unknown coronavirus was isolated from the sputum of a
60-year-old man who presented with acute pneumonia and subsequent renal
failure with a fatal outcome in Saudi Arabia.
explanation: >-
The index case developed renal failure, the characteristic extrapulmonary
manifestation. Evidence source is HUMAN_CLINICAL as this is a clinical case
report.
- category: Gastrointestinal
name: Diarrhea
description: >
Gastrointestinal symptoms including diarrhea occur in a substantial minority of
MERS cases.
phenotype_term:
preferred_term: Diarrhea
term:
id: HP:0002014
label: Diarrhea
frequency: OCCASIONAL
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
diarrhoea (12 [26%])
explanation: >-
Diarrhoea was reported in 12 of 47 patients (26%) in the primary Saudi
cohort, supporting an OCCASIONAL band. Evidence source is HUMAN_CLINICAL as
this is a clinical case series.
- category: Gastrointestinal
name: Vomiting
description: >
Vomiting occurs as part of the gastrointestinal symptom complex in a minority
of MERS cases.
phenotype_term:
preferred_term: Vomiting
term:
id: HP:0002013
label: Vomiting
frequency: OCCASIONAL
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
vomiting (ten [21%])
explanation: >-
Vomiting was reported in 10 of 47 patients (21%) in the primary Saudi
cohort, supporting an OCCASIONAL band. Evidence source is HUMAN_CLINICAL as
this is a clinical case series.
- category: Musculoskeletal
name: Myalgia
description: >
Myalgia is a common systemic symptom at presentation in MERS.
phenotype_term:
preferred_term: Myalgia
term:
id: HP:0003326
label: Myalgia
frequency: FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
myalgia (15 [32%])
explanation: >-
Myalgia was reported in 15 of 47 patients (32%) in the primary Saudi
cohort, supporting a FREQUENT band. Evidence source is HUMAN_CLINICAL as
this is a clinical case series.
- category: Hematologic
name: Lymphopenia
description: >
Lymphopenia is a characteristic laboratory feature of MERS, reflecting the
lymphotropic and immunopathologic component of severe infection.
phenotype_term:
preferred_term: Lymphopenia
term:
id: HP:0001888
label: Decreased total lymphocyte count
frequency: FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
lymphopenia (16 [34%])
explanation: >-
Lymphopenia was present in 16 of 47 patients (34%) in the primary Saudi
cohort, supporting a FREQUENT band. Evidence source is HUMAN_CLINICAL as
this is a clinical case series.
- category: Hematologic
name: Thrombocytopenia
description: >
Thrombocytopenia is a laboratory abnormality seen in a substantial minority of
MERS cases.
phenotype_term:
preferred_term: Thrombocytopenia
term:
id: HP:0001873
label: Thrombocytopenia
frequency: FREQUENT
evidence:
- reference: PMID:23891402
reference_title: "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
thrombocytopenia (17 [36%])
explanation: >-
Thrombocytopenia was present in 17 of 47 patients (36%) in the primary Saudi
cohort, supporting a FREQUENT band. Evidence source is HUMAN_CLINICAL as
this is a clinical case series.
treatments:
- name: Supportive Care
description: >
Management of MERS is primarily supportive, including supplemental oxygen and
respiratory support (up to mechanical ventilation/ECMO for ARDS); no antiviral
therapy is approved as standard of care, and management of severe disease is
organ-supportive.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
notes: >-
Created as part of the Respiratory Infections project (Intercept-aligned,
pandemic-potential coronavirus backlog item). Conforms to the
host_directed_antiviral_dependency module via the DPP4 receptor entry node,
paralleling SARS-CoV-2/ACE2. The infectious_agent (NCBITaxon) block for
MERS-CoV was omitted at creation and is described in the text; it can be added
later.